Med Check |
December 07, 2012
On October 19, Eli Lilly and Co. and Avid Radiopharmaceuticals ( a Lilly subsidiary) announced they received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in Europe, recommending approval of Amyvid (Florbetapir F 18) solution for injection as a diagnostic radiopharmaceutical indicated for positron emission tomography (PET)
...[Read More]